Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Stereoselective Fluorination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101628927A details a stereoselective route for Gemcitabine. Discover cost reduction in pharmaceutical manufacturing and high-purity oncology intermediates.
Patent CN1228342C details a novel route for Gemcitabine using 1,6-dehydro-beta-D-glucose, offering improved stereoselectivity and cost reduction in API manufacturing.